|
|||||
|
|
Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence |
|
| Authors: | E. Shirneshan PhD P. Kyrychenko MD PhD O. S. Matlin PhD J. P. Avila BA T. A. Brennan MD JD W. H. Shrank MD MSHS |
| Affiliation: | Divisions of Enterprise Research and Analytic Development, Provider Innovation & Analytic, and Product Innovation and Management, CVS Health, Northbrook, IL, USA |
| Abstract: | |
| Keywords: | drug formulary drug utilization generic utilization medication adherence pharmacy costs restrictive formulary therapy discontinuation therapy disruption |